Redeye comments on yesterday’s announcement that Hoylu carried out a directed issue of convertible l...
Redeye comments on Respiratorius following the release of its shortened fiscal year 2022 Q2 report.
Q3-rapporten Ascelia presenterade i fredags sin Q3-rapport.
Redeye’s comments on the Q3 report that was published earlier this morning.
Cantargia has presented new data concerning its IL1RAP-targeting antibody, nadunolimab (CAN04), whic...
Redeye sees a solid Q3 report from Hanza with an EBITA in line with our expectations.
NOI increased 13% y-o-y, -1% vs. ABGSCe Value gains of 0.
Sammantaget visade rapporten på nytt att Amhult 2 har hanterat förutsättningarna på ett väl sätt.
We expect order intake of DKK 3.2bn excluding JVs Sales of DKK 2,356m and EBIT (adj.
Relais will for the first time report in accordance with IFRS standards in its Q3 results on 10 Nove...
Redeye is encouraged by the news that Scibase has entered into a collaboration with Johnson & Johnso...
Redeye was rather surprised to see the announcement of Inzile filing for bankruptcy.
Redeye comments on Fluoguide posting interim data from its phase IIa trial with FG001 in NSCLC (FG00...
Blick Global Group AB (”Blick Global” eller ”Bolaget”) är en förvärvsinriktad koncern inom iGaming.
Redeye leaves a comment following Lipum’s announcement of phase I trial initiation with SOL-116.
Redeye comments on the news released on Friday, Wyld Networks has, through a directed share issue, s...
Bra kostnadskontroll Det tredje kvartalet karaktäriserades av fortsatt återhållsamhet på kostnadssid...
DevPort levererar ett rekordkvartal såväl omsättning- som lönsamhetsmässigt.
Redeye updates its estimates following Carasent’s Q3 report and the acquisitions of HPI and Confrere...
I dag offentliggjorde Spotlight Group sin delårsrapport för det tredje kvartalet 2022.
